Search for Clinical Trial Results

Sponsored By

Giant Cell Tumors - 16 Studies Found

Status Study
Recruiting Study Name: Tenosynovial Giant Cell Tumors (TGCT) Observational Platform Project
Condition: Giant Cell Tumors
Date: 2016-10-24
Completed Study Name: Safety and Efficacy Study of Denosumab in Patients With Recurrent or Unresectable Giant Cell Tumor of Bone
Condition:
  • GCT
  • Giant Cell Tumor of Bone

Date: 2006-11-02
Interventions:
  • Biological: Denosumab Administ
Terminated Study Name: Study of the Effect of Zoledronate on Local Recurrence After Surgical Treatment of Giant Cell Tumors of Bone Zométa
Condition: Giant Cell Tumors of Bone
Date: 2011-06-28
Interventions: Drug: acid Zoledronic Treatment with zoledronic acid will be initiated during hospitalization, the day a
Recruiting Study Name: Study of FPA008 in Patients With Pigmented Villonodular Synovitis / Diffuse Type Tenosynovial Giant Cell Tumor
Condition:
  • Pigmented Villonodular Synovitis
  • Tenosynovial Giant Cell Tumor<
    Date: 2015-06-01
    Interventions: Drug: FPA008 FPA008 will be administered by IV infusion over approximately 30 minutes every 2 weeks
Completed Study Name: Giant Cell Tumor of the Extremities Treated With Surgery and/or Medical Treatment
Condition: Giant Cell Tumor of Bone
Date: 2016-12-15
Interventions: Procedure: curettage and resection the investigators analyzed patients with giant cell tumor of bone who
Terminated Study Name: Adjuvant Zoledronic Acid in High Risk Giant Cell Tumour of Bone (GCT)
Condition:
  • Giant Cell Tumor of Bone
  • Osteoclastoma

Date: 2009-04-28
Interventions: Drug: Zoledronic acid 4 mg, monthly for 3 months followed by a 3-monthly schedule for up to one year aft
Active, not recruiting Study Name: PLX3397 Phase 3 Study for Pigmented Villonodular Synovitis (PVNS) or Giant Cell Tumor of the Tendon Sheath (GCT-TS)
Condition:
  • Pigmented Villonodular Synovitis
  • Giant Cell Tumors of the Tendo
    Date: 2015-02-19
    Interventions:
    • Drug: PLX3397 capsule Each cap
Active, not recruiting Study Name: Study of Denosumab in Subjects With Giant Cell Tumor of Bone
Condition:
  • Cancer
  • GCT
  • Giant Cell Tumor o
    Date: 2008-05-15
    Interventions: Drug: Denosumab 120 mg administered subcutaneously (SC) every 4 weeks (Q4W) with a loading dose of 120 m
Active, not recruiting Study Name: Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor
Condition:
  • Pigmented Villonodular Synovitis
  • Diffuse-type Giant Cell Tumor<
    Date: 2010-09-21
    Interventions: Drug: nilotinib Taken orally twice daily
Recruiting Study Name: A Study of PLX73086 in Advanced Solid Tumors and Locally Advanced or Refractory Tenosynovial Giant Cell Tumor
Condition: